Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03420508
Title Treating Patients With Melanoma and ALK Alterations With Ensartinib
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field